Results 11 to 20 of about 6,793 (233)

A case of combined large cell neuroendocrine carcinoma (LCNEC) and squamous cell carcinoma.

open access: bronzeThe Journal of the Japanese Association for Chest Surgery, 2002
症例は52歳男性.2000年1月, 胸部X線写真上, 右上肺野に急速に増大した腫瘤影を認め当院に紹介された.胸部CT上, 右上葉に11×10×9.0cm大の腫瘤を認め, 縦隔リンパ節の腫大は認めなかった.腫瘍マーカーはSLX, SCC, CYFRA, NSEが上昇していた.原発性肺癌を強く疑い, 同年1月25日に右上葉切除・ND2a・胸壁 (第3肋骨) 合併切除術を施行した.病理組織学的に扁平上皮癌の成分とLarge cell neuroendocrine carcinoma (LCNEC) の成分を混在しており, 扁平上皮癌を混在したLCNECと診断され, 術後病期はpT3N0M0, Stage II Bであった.術後経過は良好であり, 化学療法を施行せずに退院した.以後 ...
Seiichiro Sugimoto   +3 more
openalex   +3 more sources

Comprehensive analysis of pulmonary Large Cell Neuroendocrine Carcinoma (LCNEC) [PDF]

open access: gold, 2017
Neuroendocrine tumours in the lungs such as large-cell neuroendocrine carcinoma (LCNEC) are a rare occurrence in the Netherlands. Pathologists, oncologists and lung cancer oncologists are all confronted with various problems regarding the diagnosis and treatment of LCNEC. Firstly, making the diagnosis is difficult due to the lack of standards for small
Jules L. Derks
openalex   +3 more sources

LCNEC of Nasal Cavity: Diagnostic and Treatment Modalities—Case Report and a Narrative Review [PDF]

open access: diamondIndian Journal of Medical and Paediatric Oncology
Abstract Large cell neuroendocrine carcinoma (LCNEC) of the nasal cavity is a rare epithelial malignancy with only a few cases reported to date. In this article, we present a case report of a 48-year-old male, who presented with a history of epistaxis and nasal blockage for over 1 year and was initially diagnosed as undifferentiated ...
Gaurav Jalal, TVSVGK Tilak
openalex   +2 more sources

YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities [PDF]

open access: greenClinical Cancer Research
Abstract Purpose: Large cell neuroendocrine carcinoma (LCNEC) is a high-grade neuroendocrine malignancy that, like small cell lung cancer (SCLC), is associated with the absence of druggable oncogenic drivers and dismal prognosis.
C. Allison Stewart   +28 more
openalex   +3 more sources

Long lasting octreotide LAR therapy in large cell neuroendocrine carcinoma (LCNEC) of the lung

open access: goldClinical Management Issues, 2015
In this article we report a case of a patient with large cell neuroendocrine carcinoma (LCNEC) of the lung. Patients with LCNEC usually have poor prognosis and the benefit of adjuvant chemotherapy for these patients has not been fully established. This case suggests that octreotide LAR, a somatostatine analogue (SSA), can be useful in the treatment of ...
Alfredo Butera
openalex   +4 more sources

Large cell neuroendocrine tumor of lung with hemorrhagic cerebral metastasis: A case report [PDF]

open access: yesRadiology Case Reports
Large cell neuroendocrine carcinoma (LCNEC) of the lung is a rare, high-grade malignancy within the spectrum of pulmonary neuroendocrine tumors, characterized by aggressive behavior and poor prognosis.
Aalok Kumar Yadav, MD   +4 more
doaj   +2 more sources

2202P Large cell neuroendocrine carcinoma (LCNEC) subtyping based on NEUROD1, ASCL1, POU2F3 and YAP1 expression [PDF]

open access: bronzeAnnals of Oncology, 2023
Frank W J Heijboer   +8 more
openalex   +2 more sources

Two cases of combined large cell neuroendocrine carcinoma (LCNEC)

open access: diamondThe Journal of the Japanese Association for Chest Surgery, 2016
Yasuaki Kubouchi   +2 more
openalex   +3 more sources

P3.12-10 Immunogenomic Characteristics of SCLC and LCNEC Redefined Molecular Subgroups [PDF]

open access: bronzeJournal of Thoracic Oncology, 2018
Xue‐Lei Li   +7 more
openalex   +2 more sources

PS06.06 Immune Checkpoint Markers in Lung Large Cell Neuroendocrine Carcinomas (L- LCNEC) [PDF]

open access: bronzeJournal of Thoracic Oncology, 2017
Nagla Abdel Karim   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy